Amendment 2 RFP 75N93023R00013.pdf
PDF 125 KB Posted
- Attached to
- Functional Omics Core Laboratory
- Solicitation number
- 75N93023R00013
About this file
This document is Amendment #2 to Request for Proposals (RFP) No. 75N93023R00013 for a "Functional Omics Core Laboratory" solicitation. The amendment provides responses to questions from potential offerors regarding the solicitation. Key details include:
The solicitation requires offerors to propose on a set number of assays, including 2,500 bulk RNA-seq, 70 single-cell RNA-seq, 70 single-cell ATAC-seq, and 150 CITE-Seq. Offerors should adhere to the Uniform Cost Assumptions and propose costs only for the required assays, and not include additional assays in the overall cost. The proposal due date remains unchanged at May 17, 2024 at 3:00 PM local time. The solicitation is being issued by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Amendment 3 RFP 75N93023R00013.pdf | ||
| Amendment 1 RFP 75N93023R00013.pdf | ||
| Draft 75N93023R00013 with Attachment.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
AMENDMENT #2 RFP No. 75N93023R00013 1
Amendment No. 2 RFP No. 75N93023R00013
“Functional Omics Core Laboratory”
Solicitation Number: 75N93023R00013
Amendment Number: Two (2)
Amendment Issue Date: April 1, 2024
Proposal Due Date/Time: May 17, 2024, at 3:00 PM, Local Time (Unchanged)
Issued By: Karen Telphia
Contract Specialist
OA/DEA/NIAID/NIH/DHHS
5601 Fishers Lane, Room 3D10, MSC 9821 Bethesda, Maryland 20892-9821
Points of Contact: PRIMARY karen.telphia@nih.gov Karen Telphia, Contract Specialist Phone: 240.669.2960
Please note that we do NOT intend to extend the due date for submission of proposals as a result of this amendment. The date specified for receipt of proposals remains unchanged.
Offerors must acknowledge receipt of this Amendment by identifying the amendment number and the date of the amendment on each copy of the submitted proposal. Failure to receive your acknowledgement may result in the rejection of your proposal. Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.
The purpose of this Amendment is to provide responses to questions from potential offerors, regarding the solicitation.
RESPONSES TO QUESTIONS FROM POTENTIAL OFFERORS:
Question 1 If a subcontractor is included to provide a specific assay – how should they prepare their estimate of cost? Should they have standing effort for personnel or calculate their based on a unit cost of a set number of assays? Does the Prime work their cost into the overall cost of the contract bid?
mailto:karen.telphia@nih.gov
AMENDMENT #2 RFP No. 75N93023R00013 2
Response to Question 1 If you are using a subcontractor, how the subcontractor prepares their estimate of cost is based on the agreement between the subcontractor and the prime. If the agreement is based on fixed price, then the costs would be provided in a fixed price format. If the agreement is based on cost reimbursement, then the costs would be provided in a cost reimbursement format. How your subcontractor proposes costs is up to the prime.
The prime has to include the subcontractor costs into the overall cost of the proposal.
Question 2 For calculating the cost of the contract: We are proposing to offer additional assays beyond the 2500 bulk rna-seq, 70 single-cell rna-seq, 70 single-cell ATAC-seq and 150 CITE-Seq.
Should we limit our calculation of the contract cost to the effort, the cost of the 2790 listed assays and related costs, and include pricing options for the additional assays, but without adding them to the total? Or should we sum in the non-listed assays into the overall cost?
Response to Question 2 You should adhere to the Uniform Cost Assumptions which provides the required FTEs (no more and no less) and provides number of assays to propose (no more and no less). An offeror should propose costs for what is being asked and nothing “extra”.
END OF AMENDMENT NO. 2, RFP No. 75N93023R00013
File details come from the government source that posted it. Updated .